Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$209.01 - $232.56 $12,958 - $14,418
-62 Reduced 1.72%
3,545 $774,000
Q4 2023

Feb 06, 2024

SELL
$197.69 - $227.29 $43,096 - $49,549
-218 Reduced 5.7%
3,607 $819,000
Q3 2023

Nov 06, 2023

BUY
$201.05 - $221.7 $17,692 - $19,509
88 Added 2.35%
3,825 $769,000
Q2 2023

Jul 31, 2023

SELL
$211.93 - $241.33 $211 - $241
-1 Reduced 0.03%
3,737 $901,000
Q1 2023

May 09, 2023

SELL
$213.32 - $257.83 $40,957 - $49,503
-192 Reduced 4.89%
3,738 $857,000
Q4 2022

Feb 13, 2023

BUY
$203.72 - $248.97 $9,778 - $11,950
48 Added 1.24%
3,930 $925,000
Q2 2022

Aug 09, 2022

BUY
$213.86 - $277.87 $5,132 - $6,668
24 Added 0.62%
3,882 $910,000
Q1 2022

May 09, 2022

SELL
$259.82 - $298.18 $76,127 - $87,366
-293 Reduced 7.06%
3,858 $1.02 Million
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $77,677 - $89,864
-286 Reduced 6.45%
4,151 $1.3 Million
Q3 2021

Nov 15, 2021

BUY
$274.82 - $308.34 $156,922 - $176,062
571 Added 14.77%
4,437 $1.25 Million
Q2 2021

Aug 13, 2021

SELL
$251.87 - $278.14 $1.02 Million - $1.12 Million
-4,041 Reduced 51.11%
3,866 $1.07 Million
Q1 2021

May 17, 2021

BUY
$204.88 - $255.03 $821,773 - $1.02 Million
4,011 Added 102.95%
7,907 $2.02 Million
Q4 2020

Feb 16, 2021

BUY
$186.91 - $214.42 $728,201 - $835,380
3,896 New
3,896 $793,000
Q2 2020

Aug 14, 2020

SELL
$113.31 - $182.44 $709,320 - $1.14 Million
-6,260 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$104.32 - $195.28 $653,043 - $1.22 Million
6,260 New
6,260 $791,000
Q1 2019

May 08, 2019

SELL
$123.7 - $156.3 $16,081 - $20,319
-130 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$120.82 - $174.09 $15,706 - $22,631
130 New
130 $16,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Wealthspire Advisors, LLC Portfolio

Follow Wealthspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.